News
Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to ...
MONDAY, Aug. 11, 2025 (HealthDay News) — Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting ...
The amendment states that no funds appropriated in the fiscal 2026 spending bill can be used to increase the proportion of grants fully funded in the first year of the award, compared with fiscal 2024 ...
Pack your goggles, Chicago—for the first time since the Roaring Twenties, you can legally take a dip in the Chicago River. On ...
Athira Pharma (ATHA) presented results from its Phase 1 clinical trial of ATH-1105 in healthy volunteers at the ALS Nexus 2025 conference in ...
Voting is now open for panels to be part of next year’s South by Southwest (SXSW) festival, allowing anyone with an opinion ...
The Chicago River Swim (CRS) is officially coming back in September and will be held on Sunday, Sept. 21, from 7 to 10 a.m.
The M&G annually honours a cohort of South Africans who are recognised as changemakers and influencers in the work that they ...
On Sunday, October 5, the San Diego community will come together for the 24th Annual Walk to Defeat ALS, a fundraising event ...
Q2 2025 Management View Chaim Lebovits, President and CEO, reaffirmed that "our top priority is advancing NurOwn into our planned Phase IIIb clinical trial." The ENDURANCE trial is designed to confirm ...
July saw the death of heavy metal godfather Ozzy Osbourne, the Black Sabbath lead singer whose influence in the genre spans generations. Known for his music’s morbid imagery, Osbourne died ...
A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results